Boston Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-25,644
| Closed | -$402K | – | 666 |
|
|
2019
Q1 | $402K | Buy |
25,644
+2,089
| +9% | +$32.7K | 0.02% | 504 |
|
|
2018
Q4 | $363K | Buy |
23,555
+3,592
| +18% | +$55.4K | 0.02% | 502 |
|
|
2018
Q3 | $430K | Buy |
+19,963
| New | +$430K | 0.02% | 500 |
|
|
2017
Q3 | – | Sell |
-7,850
| Closed | -$261K | – | 670 |
|
|
2017
Q2 | $261K | Sell |
7,850
-7,767
| -50% | -$258K | 0.01% | 596 |
|
|
2017
Q1 | $501K | Sell |
15,617
-1,855
| -11% | -$59.5K | 0.01% | 469 |
|
|
2016
Q4 | $633K | Sell |
17,472
-134,278
| -88% | -$4.86M | 0.02% | 432 |
|
|
2016
Q3 | $6.98M | Sell |
151,750
-1,998
| -1% | -$91.9K | 0.17% | 153 |
|
|
2016
Q2 | $7.72M | Sell |
153,748
-6,669
| -4% | -$335K | 0.19% | 144 |
|
|
2016
Q1 | $8.58M | Buy |
160,417
+601
| +0.4% | +$32.2K | 0.21% | 127 |
|
|
2015
Q4 | $10.5M | Sell |
159,816
-48
| -0% | -$3.15K | 0.25% | 124 |
|
|
2015
Q3 | $9.03M | Sell |
159,864
-1,893
| -1% | -$107K | 0.34% | 86 |
|
|
2015
Q2 | $9.56M | Sell |
161,757
-8,660
| -5% | -$512K | 0.4% | 81 |
|
|
2015
Q1 | $10.6M | Buy |
170,417
+160,867
| +1,684% | +$10M | 0.42% | 75 |
|
|
2014
Q4 | $549K | Sell |
9,550
-1,800
| -16% | -$103K | 0.02% | 331 |
|
|
2014
Q3 | $610K | Hold |
11,350
| – | – | 0.03% | 322 |
|
|
2014
Q2 | $595K | Sell |
11,350
-100
| -0.9% | -$5.24K | 0.03% | 332 |
|
|
2014
Q1 | $605K | Sell |
11,450
-2,550
| -18% | -$135K | 0.03% | 318 |
|
|
2013
Q4 | $561K | Sell |
14,000
-1,450
| -9% | -$58.1K | 0.03% | 330 |
|
|
2013
Q3 | $584K | Sell |
15,450
-3,550
| -19% | -$134K | 0.03% | 307 |
|
|
2013
Q2 | $745K | Buy |
+19,000
| New | +$745K | 0.04% | 276 |
|